Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Issuances (2011 - 2014)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Long-Term Debt Issuances of -$280000.0 for Q4 2014, down 200.0% quarter-over-quarter from $280000.0 in Q3 2014.
Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Issuances (2011 - 2014) Analysis & Trends
Tonix Pharmaceuticals Holding's Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at -$280000.0 for Q4 2014.
- In Q4 2014, Long-Term Debt Issuances changed N/A year-over-year to -$280000.0; the TTM figure through Sep 2014 stood at $280000.0 (down 58.21% YoY), while the FY2023 annual figure was $8.9 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2014 stood at -$280000.0, down from $280000.0 in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $1.5 million in Q4 2011, with the low at -$280000.0 in Q4 2014.
- The 4-year median for Long-Term Debt Issuances is $240000.0 (2013), against an average of $361833.3.
- The sharpest annual moves came in 2012 and 2014: Long-Term Debt Issuances tumbled 74.02% in 2012, then soared 250.0% in 2014.
- Tonix Pharmaceuticals Holding's Long-Term Debt Issuances stood at $1.5 million in 2011, then sank by 74.02% to $390000.0 in 2012, then sank by 79.49% to $80000.0 in 2013, then slumped by 450.0% to -$280000.0 in 2014.
- Business Quant data shows TNXP's Long-Term Debt Issuances at -$280000.0 in Q4 2014, $280000.0 in Q3 2014, and $80000.0 in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -675,522.58 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -280,000.00 |
| Dec 31, 2014 | -280,000.00 |
| Sep 30, 2014 | 280,000.00 |
| Sep 30, 2014 | 280,000.00 |
| Sep 30, 2013 | 80,000.00 |
| Sep 30, 2013 | 80,000.00 |
| Jun 30, 2013 | 200,000.00 |
| Jun 30, 2013 | 200,000.00 |
| Dec 31, 2012 | 390,000.00 |
| Dec 31, 2012 | 390,000.00 |
| Dec 31, 2011 | 1.50 Mn |
| Dec 31, 2011 | 1.50 Mn |